186 related articles for article (PubMed ID: 35092434)
1. Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases.
Lowe SR; Wang CP; Brisco A; Whiting J; Arrington J; Ahmed K; Yu M; Robinson T; Oliver D; Etame A; Tran N; Beer Furlan A; Sahebjam S; Mokhtari S; Piña Y; Macaulay R; Forsyth P; Vogelbaum MA; Liu JKC
Neuro Oncol; 2022 Aug; 24(8):1307-1317. PubMed ID: 35092434
[TBL] [Abstract][Full Text] [Related]
2. Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
Johnson MD; Avkshtol V; Baschnagel AM; Meyer K; Ye H; Grills IS; Chen PY; Maitz A; Olson RE; Pieper DR; Krauss DJ
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):537-43. PubMed ID: 26867883
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer.
Trifiletti DM; Romano KD; Xu Z; Reardon KA; Sheehan J
J Neurooncol; 2015 Sep; 124(3):421-7. PubMed ID: 26093620
[TBL] [Abstract][Full Text] [Related]
4. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.
Atalar B; Modlin LA; Choi CY; Adler JR; Gibbs IC; Chang SD; Harsh GR; Li G; Nagpal S; Hanlon A; Soltys SG
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):713-8. PubMed ID: 24054875
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery.
Huang AJ; Huang KE; Page BR; Ayala-Peacock DN; Lucas JT; Lesser GJ; Laxton AW; Tatter SB; Chan MD
J Neurooncol; 2014 Oct; 120(1):163-9. PubMed ID: 25048529
[TBL] [Abstract][Full Text] [Related]
6. Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery.
Siomin VE; Vogelbaum MA; Kanner AA; Lee SY; Suh JH; Barnett GH
J Neurooncol; 2004; 67(1-2):115-21. PubMed ID: 15072456
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases.
Wolf A; Donahue B; Silverman JS; Chachoua A; Lee JK; Kondziolka D
J Neurooncol; 2017 Aug; 134(1):139-143. PubMed ID: 28536993
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiosurgery for the treatment of metastatic brain tumor: Evaluation of local failure and leptomeningeal disease.
Foreman PM; Jackson BE; Singh KP; Romeo AK; Guthrie BL; Fisher WS; Riley KO; Markert JM; Willey CD; Bredel M; Fiveash JB
J Clin Neurosci; 2018 Mar; 49():48-55. PubMed ID: 29248376
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.
Chorti E; Kebir S; Ahmed MS; Keyvani K; Umutlu L; Kanaki T; Zaremba A; Reinboldt-Jockenhoefer F; Knispel S; Gratsias E; Roesch A; Ugurel S; Scheffler B; Schadendorf D; Livingstone E; Meier F; Glas M; Zimmer L
Eur J Cancer; 2021 May; 148():395-404. PubMed ID: 33789203
[TBL] [Abstract][Full Text] [Related]
10. Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa.
Suki D; Abouassi H; Patel AJ; Sawaya R; Weinberg JS; Groves MD
J Neurosurg; 2008 Feb; 108(2):248-57. PubMed ID: 18240919
[TBL] [Abstract][Full Text] [Related]
11. Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis.
Suki D; Hatiboglu MA; Patel AJ; Weinberg JS; Groves MD; Mahajan A; Sawaya R
Neurosurgery; 2009 Apr; 64(4):664-74; discussion 674-6. PubMed ID: 19197219
[TBL] [Abstract][Full Text] [Related]
12. Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis.
Brown DA; Lu VM; Himes BT; Burns TC; Quiñones-Hinojosa A; Chaichana KL; Parney IF
Clin Exp Metastasis; 2020 Apr; 37(2):341-352. PubMed ID: 31950392
[TBL] [Abstract][Full Text] [Related]
13. Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery.
Press RH; Zhang C; Chowdhary M; Prabhu RS; Ferris MJ; Xu KM; Olson JJ; Eaton BR; Shu HG; Curran WJ; Crocker IR; Patel KR
Neurosurgery; 2019 Nov; 85(5):632-641. PubMed ID: 30335175
[TBL] [Abstract][Full Text] [Related]
14. Leptomeningeal disease in neurosurgical brain metastases patients: A systematic review and meta-analysis.
Tewarie IA; Jessurun CAC; Hulsbergen AFC; Smith TR; Mekary RA; Broekman MLD
Neurooncol Adv; 2021; 3(1):vdab162. PubMed ID: 34859226
[TBL] [Abstract][Full Text] [Related]
15. Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases.
Khaled ML; Tarhini AA; Forsyth PA; Smalley I; Piña Y
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980770
[TBL] [Abstract][Full Text] [Related]
16. Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases.
Minniti G; Lanzetta G; Capone L; Giraffa M; Russo I; Cicone F; Bozzao A; Alongi F; Nicosia L; Fineschi G; Marchetti L; Tufo T; Bianciardi F; Esposito V; Gentile P; Paolini S
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949695
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
[TBL] [Abstract][Full Text] [Related]
18. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
20. Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastases.
Nguyen TK; Sahgal A; Detsky J; Atenafu EG; Myrehaug S; Tseng CL; Husain Z; Heyn C; Maralani P; Ruschin M; Perry J; Soliman H
Neuro Oncol; 2020 Jan; 22(1):84-93. PubMed ID: 31412120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
